The potential role of GLP-1 receptor agonist targeting in fertility-sparing treatment in obese patients with endometrial malignant pathology: a call for research.

MLA

Violette, Caroline J., et al. “The Potential Role of GLP-1 Receptor Agonist Targeting in Fertility-Sparing Treatment in Obese Patients with Endometrial Malignant Pathology: A Call for Research.” Expert Review of Anticancer Therapy, vol. 23, no. 4, Apr. 2023, pp. 385–95. EBSCOhost, https://doi.org/10.1080/14737140.2023.2194636.

APA

Violette, C. J., Agarwal, R., Mandelbaum, R. S., González, J. L., Hong, K. M., Roman, L. D., Klar, M., Wright, J. D., Paulson, R. J., Obermair, A., & Matsuo, K. (2023). The potential role of GLP-1 receptor agonist targeting in fertility-sparing treatment in obese patients with endometrial malignant pathology: a call for research. Expert Review of Anticancer Therapy, 23(4), 385–395. https://doi.org/10.1080/14737140.2023.2194636

Chicago

Violette, Caroline J., Ravi Agarwal, Rachel S. Mandelbaum, José L. González, Kurt M. Hong, Lynda D. Roman, Maximilan Klar, et al. 2023. “The Potential Role of GLP-1 Receptor Agonist Targeting in Fertility-Sparing Treatment in Obese Patients with Endometrial Malignant Pathology: A Call for Research.” Expert Review of Anticancer Therapy 23 (4): 385–95. doi:10.1080/14737140.2023.2194636.